IMRT Alone for Stage IB Nasopharyngeal Carcinoma Without High-Risk Features
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-70
SponsorQiaojuan Guo
About this trial
This observational study aims to evaluate the efficacy and safety of intensity-modulated radiotherapy (IMRT) alone in patients with stage IB nasopharyngeal carcinoma (NPC) without high-risk features. The primary objective is to determine the therapeutic effectiveness of this approach
Eligibility criteria
Qualifiers
None
Disqualifiers
Age > 70 years or < 18 years
Matted lymph nodes: two or more contiguous nodes with loss of intervening fat planes and/or extracapsular extension forming a confluent mass
Largest metastatic lymph-node ≥ 3 cm in the longest dimension
Lower-neck nodal metastasis: inferior border of any positive node below the inferior border of the hyoid bone
Trial design
Treatments tested in this trial
- IMRT along
Treatment groups
169 Participants
are divided into 1 treatment groupSponsors and collaborators
Qiaojuan Guo
Lead sponsor
Fujian Cancer Hospital
Sponsor institution
Source ClinicalTrials.gov